Times are shown in your local time zone GMT
Ad-blocker Detected - Your browser has an ad-blocker enabled, please disable it for the full event experience.
Program
Explore the Conference Program
Clinical Urology Stream - Clinical Urology
Panel Discussion
Dr Sandra Elmer - The Royal Melbourne Hospital , Dr Renu Eapen - Peter MacCallum Cancer Centre, Austin Health & Olivia Newton John Cancer Centre, A/Prof Alicia Morgans - Dana-Farber Cancer Institute, A/Prof Renea Taylor - Monash Biomedicine Discovery Institute, Dr Claire de la Calle - Johns Hopkins University
Clinical Urology Stream - Clinical Urology
Genomics, targeted therapy and theranostics are rapidly changing our management of metastatic disease. But where do they all fit into the diagnostic and management algorithm? In this session, we explore the new game-changers in this space, including talks from Professor Stacy Loeb, Professor Oliver Sartor, Dr Renu Eapen & Dr Nat Lenzo followed by an engaging panel discussion on current and future applications of these emerging technologies and treatments
- -
Morning Tea
Clinical Urology Stream - Clinical Urology
Clinical Urology Stream - Clinical Urology
Whilst most of the change in prostate cancer management has been in the metastatic setting, even the treatment of localized disease is evolving. Local and international speakers will cover wide ranging topics, including PSMA PET imaging in the diagnosis of local disease, optimizing the delivery of radiation, the role of pelvic lymphadenectomy in the PSMA PET era and whether or not there is still a role for adjuvant radiation
Panel Discussion
Dr Phil Dundee - The Royal Melbourne Hospital, Peninsula Health, Australian Prostate Centre & Australian Medical Robotics Academy, Professor Louise Emmett - St Vincent’s Hospital Sydney, Professor John Yaxley - The Wesley Hospital, Professor Andrew Kneebone - Royal North Shore Hospital, Gosford Hospital, Genesis Cancer Care
- -
Lunch
Clinical Urology Stream - Clinical Urology
Clinical Urology Stream - Clinical Urology
The USPSTF recommendations a decade ago were driven by overdiagnosis and over treatment and lead to reductions in PSA screening across the western world. This session will cover the implications of those changes to screening, how the diagnostic pathway has evolved and how to optimise active surveillance for the decade ahead
- -
Afternoon Tea
Clinical Urology Stream - Clinical Urology
Clinical Urology Stream - Clinical Urology